文献速递腹部CT

基于计算机断层扫描(CT)影像组学预测结直肠癌NRAS基因状态

Predicting NRAS gene status in colorectal cancer using computed tomography (CT)-based radiomics.
PubMed 文献 · Clin Radiol · 2025-10-10

本研究基于216例结直肠癌患者的增强静脉期CT图像建立并验证影像组学模型预测NRAS基因状态,训练集151例、测试集65例。模型训练集AUC为0.803(95%CI 0.750-0.864),测试集AUC为0.766(95%CI 0.730-0.876),校准曲线显示预测概率与实际概率一致性良好。结论认为基于CT的影像组学模型可有效预测结直肠癌患者NRAS基因状态。

要点

  • 增强静脉期CT影像组学模型训练集AUC 0.803、测试集AUC 0.766,可用于预测结直肠癌NRAS状态。
  • 临床特征与NRAS基因状态无显著关联(P<0.05),模型仅纳入5个影像组学特征。
  • 校准曲线显示预测概率与实际概率一致性良好,Hosmer-Lemeshow检验无统计学显著差异。

核心结论

  • 基于CT的影像组学模型可有效预测结直肠癌患者的NRAS基因状态。

研究设计与样本

  • 研究类型为影像组学模型建立与验证研究,样本来自医院A的216例结直肠癌患者,训练集151例、测试集65例。
  • 在增强静脉期CT图像上使用ITK-SNAP勾画感兴趣区(ROI),采用方差分析筛选特征并以逻辑回归作为分类器。
  • 应用五折交叉验证确保模型稳定性与泛化性,使用Hosmer-Lemeshow检验评估校准曲线,并以临床决策曲线分析评估模型临床效用。

关键影像表现/征象

  • 临床特征与NRAS基因状态之间无显著关联(P<0.05)。
  • 共筛选出5个影像组学特征用于模型构建。

诊断标准与关键数值

  • 训练集AUC为0.803(95%CI 0.750-0.864)。
  • 测试集AUC为0.766(95%CI 0.730-0.876)。
  • 校准曲线显示训练集与测试集预测概率与实际概率一致性良好,Hosmer-Lemeshow检验无统计学显著差异(训练集χ2=6.727,P=0.56;测试集χ2=4.854,P=0.77)。
  • 临床决策曲线分析显示影像组学在预测NRAS状态方面具有临床价值。

临床应用与阅片要点

  • 原文结论认为基于CT的影像组学模型可有效预测结直肠癌患者NRAS基因状态,未给出具体阅片或报告建议。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIM: Establish and validate a radiomics models based on computed tomography (CT) images to predict NRAS status in colorectal cancer patients.

MATERIALS AND METHODS: Clinical and imaging characteristics associated with NRAS status were analysed. Imaging data from 216 colorectal cancer patients at hospital A were used, with 151 patients assigned to the training set and 65 to the test set. Regions of interest (ROIs) were delineated on enhanced venous phase CT images using ITK-SNAP. Features were selected based on analysis of variance, with logistic regression as the classifier. Five-fold cross-validation was applied to ensure model stability and generalisability. The Hosmer-Lemeshow test was used to evaluate the calibration curve, while clinical decision curve analysis assessed the clinical utility of the model.

RESULTS: No significant association was found between clinical features and NRAS gene status (P < 0.05). Five radiomic features were selected for model construction. The model achieved an area under the curve (AUC) of 0.803 (95% confidence interval [CI]: 0.750-0.864) in the training set and 0.766 (95% CI: 0.730-0.876) in the test set. Calibration curves demonstrated excellent agreement between the predicted and actual probabilities in both the training and test sets, supported by nonstatistically significant differences in the Hosmer-Lemeshow test (χ2 = 6.727, P = 0.56; χ2 = 4.854, P = 0.77). Clinical decision curve analysis demonstrated the clinical value of radiomics in predicting NRAS status.

CONCLUSION: The CT-based radiomics model effectively predicts NRAS gene status in colorectal cancer patients.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Yang Y, Zhang C, Chen J, et al. Predicting NRAS gene status in colorectal cancer using computed tomography (CT)-based radiomics. Clin Radiol. 2025. PMID: 41187697. doi:10.1016/j.crad.2025.107116

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。